New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancer Pierosandro TagliaferriMichele CaragliaSalvatore Venuta Review 08 June 2004 Pages: 1 - 10
Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22 John F. DiJosephAndrew PopplewellNitin K. Damle Original Article 30 July 2004 Pages: 11 - 24
Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals Mohamed A. Kharfan-DabajaErnesto AyalaKelvin P. Lee Original Article 16 June 2004 Pages: 25 - 36
Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant Johanna E. A. PortieljeWim H. J. KruitC. Erik Hack Original Article 19 October 2004 Pages: 37 - 43
Prospective clinical trials of biotherapies in solid tumors: a 5-year survey Alessandro OttaianoErnesto MolloPaolo Antonio Ascierto Original Article 03 July 2004 Pages: 44 - 50
In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells Peter DallIsabell HerrmannDieter Niederacher Original Article 29 July 2004 Pages: 51 - 60
Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell–autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions Andreia R. NevesLuis Felipe C. EnsinaJosé Alexandre M. Barbuto Original Article 14 September 2004 Pages: 61 - 66
Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells Katharina Gabriele HüttnerSabine Konstanze BreuerThomas Felzmann Original Article 18 August 2004 Pages: 67 - 77
Large intestine intraepithelial lymphocytes from Apc+/+ and Apc+/Min mice and their modulation by indigestible carbohydrates: the IL-15/IL-15Rα complex and CD4+CD25+ T cells are the main targets Virginie ForestFabrice PierreJean Menanteau Original Article 07 September 2004 Pages: 78 - 86
Natural killer (NK) and lymphokine-activated killer (LAK) cell functions from healthy dogs and 29 dogs with a variety of spontaneous neoplasms Jürgen FunkGabriele SchmitzEberhard Burkhardt Original Article 02 September 2004 Pages: 87 - 92